CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236

1 month ago 7
Read Entire Article
  1. Homepage
  2. Finance
  3. CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236

Related

Form 13F Rosalind Advisors For: 14 August

Form 13F Rosalind Advisors For: 14 August

55 minutes ago 0
Form 13F Clientfirst Wealth Management For: 14 August

Form 13F Clientfirst Wealth Management For: 14 August

55 minutes ago 0
Form 13F Voya Financial For: 14 August

Form 13F Voya Financial For: 14 August

55 minutes ago 0

Trending

1. steve martin
2. golden state warriors
3. nu stock
4. intuit
5. jadon sancho
6. gabe davis
7. amat stock price
8. stimulus checks
9. unh
10. unh stock

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 449
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 220
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 191
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 162
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

4 months ago 150
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved